Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1388 (LINC01388) is a long intergenic non-coding RNA (lincRNA), meaning it is a transcript over 200 nucleotides in length that does not overlap with known protein-coding genes and does not encode a protein[1][3][5]. LincRNAs, including LINC01388, are known to function at the RNA level to regulate gene expression, influence chromatin structure, participate in transcription regulation, and may have tissue- or cell-specific regulatory roles[3][5]. There is currently no direct evidence that LINC01388 serves as a therapeutic target or biomarker, nor are there known drugs interacting with it, and specific disease associations or safety/therapeutic issues have not been established based on available sources[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1388 (LINC01388).